GLP-1 receptor agonist
Also written as: GLP-1 — glucagon-like peptide-1 receptor agonist
Injectable diabetes medications that provide significant cardiovascular protection through weight loss and direct cardiac benefits.
Full Definition
Glucagon-like peptide-1 receptor agonists are injectable medications that mimic the incretin hormone GLP-1, enhancing glucose-dependent insulin secretion and slowing gastric emptying. These agents promote substantial weight loss and have demonstrated cardiovascular benefits in high-risk patients, including reduced risk of major adverse cardiovascular events. They represent a cornerstone of modern cardiovascular prevention strategies, particularly in patients with diabetes and obesity.
Usage
Usage note: Hyphenate when used as a compound modifier; distinguish from GLP-2 agonists which have different therapeutic applications.
In Context
- "The GLP-1 receptor agonist was initiated for both glycemic control and cardiovascular risk reduction." — Treatment plan documentation
- "Weekly GLP-1 receptor agonists have shown superior cardiovascular outcomes compared to daily formulations in some trials." — Pharmaceutical review